Figure 1 —
Flowchart describing the inclusion of participants in the study. The 75 patients who were included in this analysis had been treated by PD for a median of 11.5 (IQ range 5.9–28.8) months. PD = peritoneal dialysis; HD = hemodialysis; mAOPP = modified assay of advanced oxidation protein products; IQ = interquartile; SphygmoCor (Atcor Medical, Sydney, Australia).